GL1X · GenesisL1 explorer

MolNFT v1 · #17888 · protein

Crystal structure of EHV4-tk complexed with TP5A

1P75 · Thymidine kinase: “Crystal structure of EHV4-tk complexed with TP5A”. X-ray diffraction, 2 ligands (T5A, SO4), 15 pockets (best druggability 0.69). MolNFT v1 #17888 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1P75
Type
protein
Length
1,322 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thymidine kinase
EC
2.7.1.21
UniProt
P24425
Ligands
T5A, SO4
Pockets
15 · best druggability 0.69

Structure

x-ray diffraction · 4 distinct chains · 51% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThymidine kinase (EC 2.7.1.21)protein33149% helix, 14% strandP24425
BThymidine kinase (EC 2.7.1.21)protein33352% helix, 12% strandP24425
CThymidine kinase (EC 2.7.1.21)protein33052% helix, 15% strandP24425
DThymidine kinase (EC 2.7.1.21)protein32852% helix, 12% strandP24425

Ligands and binding sites

  • T5A · P1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate · ligand · 4 copies · chains A, B, C, D
  • SO4 · Sulfate ion · ion · 16 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14180.690.8136empty
22350.660.8427empty
34650.650.7753T5A
43680.640.7941T5A
53140.630.7934T5A

Interfaces

3 interfaces between chains.

  • C–D · 2100 Ų buried · 21 hydrogen bonds · protein-protein
  • A–B · 1941 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 803 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 1P75 · Crystal structure of EHV4-TK complexed with TP5A · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.